About
As Chief Technical Officer, my work at ADC Therapeutics is focused on ensuring safe…
Activity
-
FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic…
FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic…
Liked by David Ege, PhD
-
🌟Recently at Executive Platforms Biomanufacturing World Summit, I joined an engaging panel discussion with Pat Yang Vice Chairman & Co-Founder of…
🌟Recently at Executive Platforms Biomanufacturing World Summit, I joined an engaging panel discussion with Pat Yang Vice Chairman & Co-Founder of…
Liked by David Ege, PhD
-
I'm excited to share this encouraging data for cancer patients. Very proud of the team as we work hard to further advance this study.
I'm excited to share this encouraging data for cancer patients. Very proud of the team as we work hard to further advance this study.
Shared by David Ege, PhD
Experience
Education
More activity by David
-
We’re pleased to announce positive initial data from the LOTIS-7 Phase 1b open-label clinical trial evaluating the safety and efficacy of our…
We’re pleased to announce positive initial data from the LOTIS-7 Phase 1b open-label clinical trial evaluating the safety and efficacy of our…
Liked by David Ege, PhD
-
We’re pleased to announce publication in The Lancet Haematology of data from the investigator-initiated Phase 2 clinical trial evaluating our…
We’re pleased to announce publication in The Lancet Haematology of data from the investigator-initiated Phase 2 clinical trial evaluating our…
Liked by David Ege, PhD
-
Today we're thrilled to announce that our lead live biotherapeutic, SER-155, has received Breakthrough Therapy Designation from the FDA for the…
Today we're thrilled to announce that our lead live biotherapeutic, SER-155, has received Breakthrough Therapy Designation from the FDA for the…
Liked by David Ege, PhD
-
Over the years, I’ve come to appreciate the unique tradition and beauty of Thanksgiving. It's more than a meal, football, or shopping- it’s a season…
Over the years, I’ve come to appreciate the unique tradition and beauty of Thanksgiving. It's more than a meal, football, or shopping- it’s a season…
Liked by David Ege, PhD
-
A little over four years ago, I had the great privilege of being entrusted with building and leading Resilience. It feels like just yesterday that we…
A little over four years ago, I had the great privilege of being entrusted with building and leading Resilience. It feels like just yesterday that we…
Liked by David Ege, PhD
-
🌍 Today marks an exciting milestone for our Manufacturing & Supply teams worldwide! After celebrating the official opening of Sanofi’s first…
🌍 Today marks an exciting milestone for our Manufacturing & Supply teams worldwide! After celebrating the official opening of Sanofi’s first…
Liked by David Ege, PhD
-
Thrilled to join this exceptional team!
Thrilled to join this exceptional team!
Liked by David Ege, PhD
-
Great time last night at the Jubilee Housing Raise the Roof event. As noted at the event by a speaker the MLK Library was a great venue in both…
Great time last night at the Jubilee Housing Raise the Roof event. As noted at the event by a speaker the MLK Library was a great venue in both…
Liked by David Ege, PhD
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More